Activist investor Elliott Investment Management has acquired a stake in BioMarin Pharmaceutical (NASDAQ: BMRN), according to Reuters. The hedge fund ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE